Cardiovascular Disease (CVD) Completed Phase 4 Trials for Ticagrelor (DB08816)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270242Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary InterventionSupportive Care
NCT02094963Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive ManagementTreatment
NCT02587260Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)Treatment